HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK256471

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - GSK256471: 1

Experts

1.	Cluderay, Jane E: 1 article (02/2010)
2.	Dada, Adeshola: 1 article (02/2010)
3.	Davies, Ceri H: 1 article (02/2010)
4.	Dawson, Lee A: 1 article (02/2010)
5.	Hagan, Jim J: 1 article (02/2010)
6.	Hill, Mark D: 1 article (02/2010)
7.	Jones, Declan N C: 1 article (02/2010)
8.	Jones, Gareth A: 1 article (02/2010)
9.	Langmead, Christopher J: 1 article (02/2010)
10.	Murkitt, Graham S: 1 article (02/2010)

Related Diseases

1.	Schizophrenia (Dementia Praecox) 02/10/2010 - "Taken together, these in vitro and in vivo characterisations of the tachykinin NK(3) receptor antagonists GSK172981 and GSK256471 support their potential utility in the treatment of schizophrenia."

Related Drugs and Biologics

1.	Neurokinin-3 Receptors
2.	Tachykinins
3.	3-amino-N-(cyclopropyl (phenyl)methyl)- 2- (3- fluorophenyl)- 4- quinolinecarboxamide